Yantai Dongcheng Pharmaceutical Co Ltd002675
▲ PositiveCapitalrelevance
Company announced a 100 million yuan share buyback, signaling confidence and supporting stock price.

Dongcheng Pharmaceutical announced that as of July 31, 2026, the company had repurchased 7.4 million shares, accounting for 0.90% of total share capital, with a total repurchase amount of 100 million yuan. The highest transaction price was 15.27 yuan per share, and the lowest was 12.15 yuan per share. In the first quarter of 2026, the company achieved revenue of 626 million yuan and net profit attributable to the parent company of 33.44 million yuan.
Yantai Dongcheng Pharmaceutical Co LtdCompany announced a 100 million yuan share buyback, signaling confidence and supporting stock price.